AQR Capital Management »

Revance Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $515k 99k 5.19
2024-06-30 $516k 201k 2.57
2024-03-31 $148k 30k 4.92
2023-06-30 $341k 14k 25.31
2023-03-31 $457k 14k 32.21
2021-09-30 $270k 9.7k 27.86
2021-06-30 $287k 9.7k 29.62
2021-03-31 $453k 16k 27.95
2020-12-31 $499k 18k 28.36
2020-09-30 $506k 20k 25.12
2020-06-30 $325k 13k 24.43
2018-09-30 $364k 13k 27.47
2018-06-30 $364k 13k 27.47
2018-03-31 $407k 13k 30.81
2017-12-31 $460k 13k 35.79
2017-09-30 $286k 10k 27.52
2016-06-30 $164k 12k 13.58
2016-03-31 $265k 15k 17.45
2015-12-31 $428k 13k 34.18